Chronic Kidney Disease Market: 5 Emerging Therapies to Watch as the Treatment Landscape Expected to Evolve by 2036 | DelveInsight
A diversified late-stage pipeline encompassing endothelin receptor antagonists, aldosterone synthase inhibitors such as lorundrostat, APOL1 inhibitors including MZE829, and cell therapy approaches such as rilparencel is poised to intensify competition, with each modality addressing...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Speediance schlägt ein neues Kapitel auf: Vom intelligenten Heimfitnessgerät zum KI-gestützten Fitnessunternehmen
- Horizon Commerce and Pacvue Expand Strategic Partnership to Connect Retail Media Planning, Activation and Measurement
- ZOOMLION completa la primera entrega del DX7004, el tractor híbrido de ruedas más potente del mundo
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →